Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |